Please assess the completion status of the following clinical trial:

Trial Title: Remote Ischemic Conditioning and Atrial Fibrillation After Coronary Artery Bypass Grafting (CABG)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Elective on-pump CABG surgery~* Informed consent~Exclusion Criteria:~* Prior cardiac surgery (Re-operations)~* Prior atrial fibrillation~* Use of class 1 or 3 anti arrhythmic medication or digoxin Use of intermittent aortic cross clamping during surgery~* Age \<18 years~* Left ventricular ejection fraction ≤30%~* Serious pulmonary disease (resting pO2 \<90% at room air)~* Renal failure (clearance \<30 ml/min as calculated using the Modification of Diet in Renal Disease formula)~* Liver failure~* Use of the sulfonylurea derivative glibenclamide (this drug is known to block any preconditioning stimulus

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Preconditioning (Type: EXPERIMENTAL): The remote ischemic stimulus will be applied after induction of anaesthesia, but before cardiopulmonary bypass.
- Postconditioning (Type: EXPERIMENTAL): The remote ischemic stimulus during cardiopulmonary bypass.
- Pre and postconditioning (Type: EXPERIMENTAL): The remote ischemic stimulus will be applied twice, after induction of anaesthesia and during cardiopulmonary bypass.
- Control (Type: SHAM_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).